Precision Medicine: Opportunities And Challenges For Clinical Trials

The momentum and muscle behind "finding the right drug for the right patient at the right dose" has further escalated with President Barack Obama’s announcement of a $215 million dollar Precision Medicine Initiative. In this webinar, Dr. Frank Smith will explore advances in precision medicine and how it is affecting clinical research. As a pediatric hematologist/oncologist, he will use his extensive clinical and research background as a backdrop for the discussion. Topics will include: the evolution of "personalized medicine" to "precision medicine", how state-of-the-art molecular biology is creating new diagnostic and prognostic strategies, how these new strategies are helping inform the design of clinical trials, and case study: How precision medicine is improving clinical trials in hematology and oncology.